Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy.

Hartmans E, Tjalma JJJ, Linssen MD, Allende PBG, Koller M, Jorritsma-Smit A, Nery MESO, Elias SG, Karrenbeld A, de Vries EGE, Kleibeuker JH, van Dam GM, Robinson DJ, Ntziachristos V, Nagengast WB.

Theranostics. 2018 Feb 5;8(6):1458-1467. doi: 10.7150/thno.22033. eCollection 2018.

2.

Evolution in sentinel lymph node biopsy in breast cancer.

Qiu SQ, Zhang GJ, Jansen L, de Vries J, Schröder CP, de Vries EGE, van Dam GM.

Crit Rev Oncol Hematol. 2018 Mar;123:83-94. doi: 10.1016/j.critrevonc.2017.09.010. Epub 2017 Sep 20. Review.

PMID:
29482783
3.

Validation and update of a lymph node metastasis prediction model for breast cancer.

Qiu SQ, Aarnink M, van Maaren MC, Dorrius MD, Bhattacharya A, Veltman J, Klazen CAH, Korte JH, Estourgie SH, Ott P, Kelder W, Zeng HC, Koffijberg H, Zhang GJ, van Dam GM, Siesling S.

Eur J Surg Oncol. 2018 May;44(5):700-707. doi: 10.1016/j.ejso.2017.12.008. Epub 2018 Jan 17.

PMID:
29449047
4.

Ex Vivo Tracer Efficacy in Optical Imaging of Staphylococcus Aureus Nuclease Activity.

Rosman CWK, Romero Pastrana F, Buist G, Heuker M, van Oosten M, McNamara JO, van Dam GM, van Dijl JM.

Sci Rep. 2018 Jan 22;8(1):1305. doi: 10.1038/s41598-018-19289-y.

5.

Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A.

Nagengast WB, Hartmans E, Garcia-Allende PB, Peters FTM, Linssen MD, Koch M, Koller M, Tjalma JJJ, Karrenbeld A, Jorritsma-Smit A, Kleibeuker JH, van Dam GM, Ntziachristos V.

Gut. 2017 Dec 15. pii: gutjnl-2017-314953. doi: 10.1136/gutjnl-2017-314953. [Epub ahead of print] No abstract available.

6.

Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe.

Romero Pastrana F, Thompson JM, Heuker M, Hoekstra H, Dillen CA, Ortines RV, Ashbaugh AG, Pickett JE, Linssen MD, Bernthal NM, Francis KP, Buist G, van Oosten M, van Dam GM, Thorek DLJ, Miller LS, van Dijl JM.

Virulence. 2018 Jan 1;9(1):262-272. doi: 10.1080/21505594.2017.1403004. Epub 2017 Dec 26.

PMID:
29166841
7.

Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer.

Koller M, Hartmans E, de Groot DJA, Zhao XJ, van Dam GM, Nagengast WB, Fehrmann RSN.

J Nucl Med. 2017 Dec;58(12):1899-1903. doi: 10.2967/jnumed.117.198440. Epub 2017 Oct 19.

PMID:
29051346
8.

In vitro imaging of bacteria using 18F-fluorodeoxyglucose micro positron emission tomography.

Heuker M, Sijbesma JWA, Suárez RA, de Jong JR, Boersma HH, Luurtsema G, Elsinga PH, Glaudemans AWJM, van Dam GM, van Dijl JM, Slart RHJA, van Oosten M.

Sci Rep. 2017 Jul 10;7(1):4973. doi: 10.1038/s41598-017-05403-z.

9.

Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines.

Hartmans E, Linssen MD, Sikkens C, Levens A, Witjes MJH, van Dam GM, Nagengast WB.

Oncotarget. 2017 May 2;8(18):29846-29856. doi: 10.18632/oncotarget.16165.

10.

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.

Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, van Ginkel RJ, Been LB, de Jong JS, Kats-Ugurlu G, Linssen MD, Jorritsma-Smit A, van Oosten M, Nagengast WB, Ntziachristos V, van Dam GM.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):283-290. doi: 10.1016/S2468-1253(16)30082-6. Epub 2016 Sep 17.

PMID:
28404198
11.

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.

Hartmans E, Orian-Rousseau V, Matzke-Ogi A, Karrenbeld A, de Groot DJ, de Jong S, van Dam GM, Fehrmann RS, Nagengast WB.

Theranostics. 2017 Jan 6;7(2):482-492. doi: 10.7150/thno.16816. eCollection 2017.

12.

Effects of Remote Ischemic Preconditioning on Heme Oxygenase-1 Expression and Cutaneous Wound Repair.

Cremers NA, Wever KE, Wong RJ, van Rheden RE, Vermeij EA, van Dam GM, Carels CE, Lundvig DM, Wagener FA.

Int J Mol Sci. 2017 Feb 17;18(2). pii: E438. doi: 10.3390/ijms18020438.

13.

Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.

Lamberts LE, Koch M, de Jong JS, Adams ALL, Glatz J, Kranendonk MEG, Terwisscha van Scheltinga AGT, Jansen L, de Vries J, Lub-de Hooge MN, Schröder CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WPTM, Van der Wall E, van Diest PJ, de Vries EGE, Ntziachristos V, van Dam GM.

Clin Cancer Res. 2017 Jun 1;23(11):2730-2741. doi: 10.1158/1078-0432.CCR-16-0437. Epub 2016 Nov 9.

PMID:
28119364
14.

Preclinical Evaluation of Photoacoustic Imaging as a Novel Noninvasive Approach to Detect an Orthopaedic Implant Infection.

Wang Y, Thompson JM, Ashbaugh AG, Khodakivskyi P, Budin G, Sinisi R, Heinmiller A, van Oosten M, van Dijl JM, van Dam GM, Francis KP, Bernthal NM, Dubikovskaya EA, Miller LS.

J Am Acad Orthop Surg. 2017 Feb;25 Suppl 1:S7-S12. doi: 10.5435/JAAOS-D-16-00630.

PMID:
27941556
15.

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.

Koch M, de Jong JS, Glatz J, Symvoulidis P, Lamberts LE, Adams AL, Kranendonk ME, Terwisscha van Scheltinga AG, Aichler M, Jansen L, de Vries J, Lub-de Hooge MN, Schröder CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WP, Van der Wall E, Garcia-Allende PB, van Diest PJ, de Vries EG, Walch A, van Dam GM, Ntziachristos V.

Cancer Res. 2017 Feb 1;77(3):623-631. doi: 10.1158/0008-5472.CAN-16-1773. Epub 2016 Nov 22.

16.

Identification of novel therapeutic targets in anaplastic thyroid carcinoma using functional genomic mRNA-profiling: Paving the way for new avenues?

Jonker PK, van Dam GM, Oosting SF, Kruijff S, Fehrmann RS.

Surgery. 2017 Jan;161(1):202-211. doi: 10.1016/j.surg.2016.06.064. Epub 2016 Nov 16.

PMID:
27865593
17.

Near-infrared fluorescence cholangiography assisted laparoscopic cholecystectomy versus conventional laparoscopic cholecystectomy (FALCON trial): study protocol for a multicentre randomised controlled trial.

van den Bos J, Schols RM, Luyer MD, van Dam RM, Vahrmeijer AL, Meijerink WJ, Gobardhan PD, van Dam GM, Bouvy ND, Stassen LP.

BMJ Open. 2016 Aug 26;6(8):e011668. doi: 10.1136/bmjopen-2016-011668.

18.

Preclinical studies and prospective clinical applications for bacteria-targeted imaging: the future is bright.

Heuker M, Gomes A, van Dijl JM, van Dam GM, Friedrich AW, Sinha B, van Oosten M.

Clin Transl Imaging. 2016;4:253-264. Epub 2016 Jul 16. Review.

19.

Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment.

Warram JM, de Boer E, van Dam GM, Moore LS, Bevans SL, Walsh EM, Young ES, Carroll WR, Stevens TM, Rosenthal EL.

J Pathol Clin Res. 2016 Mar 2;2(2):104-12. doi: 10.1002/cjp2.40. eCollection 2016 Apr.

20.

Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism.

van der Plas WY, Engelsman AF, Özyilmaz A, van der Horst-Schrivers AN, Meijer K, van Dam GM, Pol RA, de Borst MH, Kruijff S.

Ann Surg Oncol. 2017 Jan;24(1):15-22. doi: 10.1245/s10434-016-5450-6. Epub 2016 Jul 26.

21.

Optoacoustic Imaging of Human Vasculature: Feasibility by Using a Handheld Probe.

Taruttis A, Timmermans AC, Wouters PC, Kacprowicz M, van Dam GM, Ntziachristos V.

Radiology. 2016 Oct;281(1):256-63. doi: 10.1148/radiol.2016152160. Epub 2016 Jul 4.

PMID:
27379543
22.

Emerging Targets in Photopharmacology.

Lerch MM, Hansen MJ, van Dam GM, Szymanski W, Feringa BL.

Angew Chem Int Ed Engl. 2016 Sep 5;55(37):10978-99. doi: 10.1002/anie.201601931. Epub 2016 Jul 4. Review.

PMID:
27376241
23.

Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.

Moore LS, de Boer E, Warram JM, Tucker MD, Carroll WR, Korb ML, Brandwein-Gensler MS, van Dam GM, Rosenthal EL.

Cancer Med. 2016 Jul;5(7):1526-34. doi: 10.1002/cam4.752. Epub 2016 May 11.

24.

A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound.

Qiu SQ, Zeng HC, Zhang F, Chen C, Huang WH, Pleijhuis RG, Wu JD, van Dam GM, Zhang GJ.

Sci Rep. 2016 Feb 15;6:21196. doi: 10.1038/srep21196.

25.

A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping.

Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, van Dam GM, Hoekstra HJ.

Eur J Surg Oncol. 2016 Apr;42(4):466-73. doi: 10.1016/j.ejso.2015.12.007. Epub 2016 Jan 18. Review.

PMID:
26853759
26.

Emerging Opportunities for c-MET Visualization in the Clinic.

Pool M, van Dam GM, de Vries EG.

J Nucl Med. 2016 May;57(5):663-4. doi: 10.2967/jnumed.115.169771. Epub 2016 Jan 28. No abstract available.

27.

[The Warburg effect and its role in tumour metabolism: opportunities for new cancer treatments].

van Horssen R, Freire Jorge P, van Dam GM, Nijsten MW.

Ned Tijdschr Geneeskd. 2016;160:A9489. Dutch.

PMID:
26813013
28.

Mechanical Stress Changes the Complex Interplay Between HO-1, Inflammation and Fibrosis, During Excisional Wound Repair.

Cremers NA, Suttorp M, Gerritsen MM, Wong RJ, van Run-van Breda C, van Dam GM, Brouwer KM, Kuijpers-Jagtman AM, Carels CE, Lundvig DM, Wagener FA.

Front Med (Lausanne). 2015 Dec 15;2:86. doi: 10.3389/fmed.2015.00086. eCollection 2015.

29.

Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection.

Tjalma JJ, Garcia-Allende PB, Hartmans E, Terwisscha van Scheltinga AG, Boersma-van Ek W, Glatz J, Koch M, van Herwaarden YJ, Bisseling TM, Nagtegaal ID, Timmer-Bosscha H, Koornstra JJ, Karrenbeld A, Kleibeuker JH, van Dam GM, Ntziachristos V, Nagengast WB.

J Nucl Med. 2016 Mar;57(3):480-5. doi: 10.2967/jnumed.115.166975. Epub 2015 Dec 17.

30.

Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.

Rosenthal EL, Warram JM, de Boer E, Basilion JP, Biel MA, Bogyo M, Bouvet M, Brigman BE, Colson YL, DeMeester SR, Gurtner GC, Ishizawa T, Jacobs PM, Keereweer S, Liao JC, Nguyen QT, Olson JM, Paulsen KD, Rieves D, Sumer BD, Tweedle MF, Vahrmeijer AL, Weichert JP, Wilson BC, Zenn MR, Zinn KR, van Dam GM.

J Nucl Med. 2016 Jan;57(1):144-50. doi: 10.2967/jnumed.115.158915. Epub 2015 Oct 8.

31.

Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets.

Jager NA, Wallis de Vries BM, Hillebrands JL, Harlaar NJ, Tio RA, Slart RH, van Dam GM, Boersma HH, Zeebregts CJ, Westra J.

Mol Imaging Biol. 2016 Apr;18(2):283-91. doi: 10.1007/s11307-015-0882-0.

32.

Validity of the BreastConservation! nomogram evaluated.

Pleijhuis RG, Kwast AB, Jansen L, de Vries J, Wiggers T, Siesling S, van Dam GM.

Breast. 2015 Oct;24(5):540-2. doi: 10.1016/j.breast.2015.07.001. Epub 2015 Sep 4. No abstract available.

PMID:
26346587
33.

Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer.

de Boer E, Crane LM, van Oosten M, van der Vegt B, van der Sluis T, Kooijman P, Low PS, van der Zee AG, Arts HJ, van Dam GM, Bart J.

PLoS One. 2015 Aug 6;10(8):e0135012. doi: 10.1371/journal.pone.0135012. eCollection 2015.

34.

In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas.

de Boer E, Warram JM, Tucker MD, Hartman YE, Moore LS, de Jong JS, Chung TK, Korb ML, Zinn KR, van Dam GM, Rosenthal EL, Brandwein-Gensler MS.

Sci Rep. 2015 Jun 29;5:10169. doi: 10.1038/srep10169.

35.

Targeted imaging of bacterial infections: advances, hurdles and hopes.

van Oosten M, Hahn M, Crane LM, Pleijhuis RG, Francis KP, van Dijl JM, van Dam GM.

FEMS Microbiol Rev. 2015 Nov;39(6):892-916. doi: 10.1093/femsre/fuv029. Epub 2015 Jun 24. Review.

PMID:
26109599
36.

On the horizon: Optical imaging for cutaneous squamous cell carcinoma.

de Boer E, Moore LS, Warram JM, Huang CC, Brandwein-Gensler MS, van Dam GM, Rosenthal EL, Schmalbach CE.

Head Neck. 2016 Apr;38 Suppl 1:E2204-13. doi: 10.1002/hed.24079. Epub 2015 Jul 20. Review.

PMID:
25899874
37.

Mesoscopic and macroscopic optoacoustic imaging of cancer.

Taruttis A, van Dam GM, Ntziachristos V.

Cancer Res. 2015 Apr 15;75(8):1548-59. doi: 10.1158/0008-5472.CAN-14-2522. Epub 2015 Apr 2. Review.

PMID:
25836718
38.

Molecular imaging of infectious and inflammatory diseases: a terra incognita.

Glaudemans AW, Slart RH, van Dijl JM, van Oosten M, van Dam GM.

J Nucl Med. 2015 May;56(5):659-61. doi: 10.2967/jnumed.115.155119. Epub 2015 Mar 26. No abstract available.

39.

The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas-a critical review.

Motekallemi A, Jeltema HR, Metzemaekers JD, van Dam GM, Crane LM, Groen RJ.

Neurosurg Rev. 2015 Oct;38(4):619-28. doi: 10.1007/s10143-015-0615-5. Epub 2015 Mar 5. Review.

40.

Optical innovations in surgery.

de Boer E, Harlaar NJ, Taruttis A, Nagengast WB, Rosenthal EL, Ntziachristos V, van Dam GM.

Br J Surg. 2015 Jan;102(2):e56-72. doi: 10.1002/bjs.9713. Review.

PMID:
25627136
41.

Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque.

Jager NA, Westra J, Golestani R, van Dam GM, Low PS, Tio RA, Slart RH, Boersma HH, Bijl M, Zeebregts CJ.

J Nucl Med. 2014 Dec;55(12):1945-51. doi: 10.2967/jnumed.114.143180. Epub 2014 Oct 30.

42.

A standardized light-emitting diode device for photoimmunotherapy.

de Boer E, Warram JM, Hartmans E, Bremer PJ, Bijl B, Crane LM, Nagengast WB, Rosenthal EL, van Dam GM.

J Nucl Med. 2014 Nov;55(11):1893-8. doi: 10.2967/jnumed.114.142299. Epub 2014 Oct 14.

43.

Antibody-based imaging strategies for cancer.

Warram JM, de Boer E, Sorace AG, Chung TK, Kim H, Pleijhuis RG, van Dam GM, Rosenthal EL.

Cancer Metastasis Rev. 2014 Sep;33(2-3):809-22. doi: 10.1007/s10555-014-9505-5. Review.

44.

Video-rate optical flow corrected intraoperative functional fluorescence imaging.

Koch M, Glatz J, Ermolayev V, de Vries EG, van Dam GM, Englmeier KH, Ntziachristos V.

J Biomed Opt. 2014 Apr;19(4):046012. doi: 10.1117/1.JBO.19.4.046012.

PMID:
24752380
45.

Near-infrared fluorescence laparoscopy of the cystic duct and artery in pigs: performance of a preclinical dye.

Schols RM, Lodewick TM, Bouvy ND, van Dam DA, Meijerink WJ, van Dam GM, Dejong CH, Stassen LP.

J Laparoendosc Adv Surg Tech A. 2014 May;24(5):318-22. doi: 10.1089/lap.2013.0590. Epub 2014 Apr 17.

PMID:
24742306
46.

Application of a new dye for near-infrared fluorescence laparoscopy of the ureters: demonstration in a pig model.

Schols RM, Lodewick TM, Bouvy ND, van Dam GM, Dejong CH, Stassen LP.

Dis Colon Rectum. 2014 Mar;57(3):407-11. doi: 10.1097/DCR.0000000000000055.

PMID:
24509470
47.

Towards clinically translatable NIR fluorescence molecular guidance for colonoscopy.

Garcia-Allende PB, Glatz J, Koch M, Tjalma JJ, Hartmans E, Terwisscha van Scheltinga AG, Symvoulidis P, van Dam GM, Nagengast WB, Ntziachristos V.

Biomed Opt Express. 2013 Dec 4;5(1):78-92. doi: 10.1364/BOE.5.000078. eCollection 2013 Dec 4.

48.

Towards a successful clinical implementation of fluorescence-guided surgery.

Snoeks TJ, van Driel PB, Keereweer S, Aime S, Brindle KM, van Dam GM, Löwik CW, Ntziachristos V, Vahrmeijer AL.

Mol Imaging Biol. 2014 Apr;16(2):147-51. doi: 10.1007/s11307-013-0707-y.

PMID:
24249642
49.

Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin.

van Oosten M, Schäfer T, Gazendam JA, Ohlsen K, Tsompanidou E, de Goffau MC, Harmsen HJ, Crane LM, Lim E, Francis KP, Cheung L, Olive M, Ntziachristos V, van Dijl JM, van Dam GM.

Nat Commun. 2013;4:2584. doi: 10.1038/ncomms3584.

PMID:
24129412
50.

Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery.

Kijanka M, Warnders FJ, El Khattabi M, Lub-de Hooge M, van Dam GM, Ntziachristos V, de Vries L, Oliveira S, van Bergen En Henegouwen PM.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1718-29. doi: 10.1007/s00259-013-2471-2. Epub 2013 Jun 19.

PMID:
23778558

Supplemental Content

Loading ...
Support Center